{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:01:45Z","timestamp":1785492105626,"version":"3.56.0"},"reference-count":39,"publisher":"Akademiai Kiado Zrt.","issue":"48","license":[{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2025,11,30]]},"abstract":"Az idegh\u00e1rty\u00e1t \u00e9rint\u0151 paraneoplasi\u00e1s szindr\u00f3m\u00e1k klinikai t\u00fcnetei v\u00e1ltozatosak,\n felismer\u00e9s\u00fck neh\u00e9z. A szemt\u00fcnetek gyakran els\u0151 t\u00fcnetk\u00e9nt jelentkeznek, m\u00e9g a\n daganatos megbeteged\u00e9s diagn\u00f3zisa el\u0151tt, ez\u00e9rt felismer\u00e9s\u00fck nagy jelent\u0151s\u00e9g\u0171.\n K\u00f6zlem\u00e9ny\u00fcnkben a retin\u00e1t \u00e9rint\u0151 paraneoplasi\u00e1s szindr\u00f3m\u00e1k: a tumorral t\u00e1rsult\n retinopathia, a melanom\u00e1val t\u00e1rsult retinopathia, a paraneoplasi\u00e1s vitelliformis\n maculopathia, a paraneoplasi\u00e1s opticus neuropathia \u00e9s a bilater\u00e1lis diff\u00faz\n uvealis melanocytaprolifer\u00e1ci\u00f3 ritka entit\u00e1sait ismertetj\u00fck. C\u00e9lunk a\n paraneoplasi\u00e1s szem\u00e9szeti szindr\u00f3m\u00e1k korai felismer\u00e9s\u00e9vel, multidiszciplin\u00e1ris\n megk\u00f6zel\u00edt\u00e9s\u00e9vel hozz\u00e1j\u00e1rulni a daganatos betegs\u00e9gek korai diagn\u00f3zis\u00e1hoz \u00e9s\n gyors, adekv\u00e1t kezel\u00e9s\u00e9hez. Orv Hetil. 2025; 166(48): 1898\u20131907.<\/jats:p>","DOI":"10.1556\/650.2025.33434","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:09:46Z","timestamp":1764720586000},"page":"1898-1907","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":1,"title":["Az idegh\u00e1rty\u00e1t \u00e9rint\u0151 paraneoplasi\u00e1s szindr\u00f3m\u00e1k \u00e1ttekint\u00e9se k\u00e9t eset illusztr\u00e1l\u00e1s\u00e1val"],"prefix":"10.1556","volume":"166","author":[{"given":"Hanna","family":"Barsi","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"Fazekas","sequence":"additional","affiliation":[{"name":"Gy\u0151r-Moson-Sopron V\u00e1rmegyei Petz Alad\u00e1r Egyetemi Oktat\u00f3 K\u00f3rh\u00e1z Gy\u0151r Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika Budapest, \u00dcll\u0151i \u00fat 26., 1085 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0558-1276","authenticated-orcid":true,"given":"Zsuzsanna","family":"Szepessy","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szem\u00e9szeti Klinika Budapest, \u00dcll\u0151i \u00fat 26., 1085 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Sarkar P, Mehtani A, Gandhi HC, et al. Paraneoplastic ocular\n syndrome: a pandora\u2019s box of underlying malignancies. Eye 2022; 36: 1355-1367.\n https:\/\/doi.org\/10.1038\/s41433-021-01676-x","DOI":"10.1038\/s41433-021-01676-x"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes. Oxford University\n Press, New York, NY, 2011.\n https:\/\/doi.org\/10.1093\/med\/9780199772735.001.1","DOI":"10.1093\/med\/9780199772735.001.1"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Fodor E, Sill\u00f3 P, Luk\u00e1cs A, et al. Ocular paraneoplastic pemphigoid.\n [Szem\u00e9szeti \u00e9rintetts\u00e9ggel j\u00e1r\u00f3 paraneoplasi\u00e1s pemphigoid.] Orv Hetil. 2022;\n 163: 720-725. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2022.32441","DOI":"10.1556\/650.2022.32441"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Szekanecz Z, Gomez I, So\u00f3s B, et al. Oncorheumatology: relationship\n between malignancies and musculoskeletal diseases. [Onkoreumatol\u00f3gia: a\n daganatos \u00e9s mozg\u00e1sszervi k\u00f3rk\u00e9pek \u00f6sszef\u00fcgg\u00e9sei.] Orv Hetil. 2020; 161:\n 1151-1165. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2020.31800","DOI":"10.1556\/650.2020.31800"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Kremzer T, Pete I, Ruttner P, et al. Synchronous tumor treatment in\n the presence of gynecologycal cancer in three patients. [N\u0151gy\u00f3gy\u00e1szati daganatok\n eset\u00e9n jelentkez\u0151 szinkron tumorok egy\u00fcl\u00e9sben val\u00f3 ell\u00e1t\u00e1sa h\u00e1rom eset kapcs\u00e1n.]\n Orv Hetil. 2023; 164: 70-75. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2023.32677","DOI":"10.1556\/650.2023.32677"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Koll\u00e1r R, Leel-\u0150ssy T, P\u00e1lffy V, et al. Review of bone health in\n women receiving endocrine therapy because of breast cancer. [Az eml\u0151r\u00e1k kezel\u00e9se\n sor\u00e1n alkalmazott hormonter\u00e1pia csonthat\u00e1sainak \u00e1ttekint\u00e9se.] Orv Hetil. 2024;\n 165: 813-821. [Hungarian]","DOI":"10.1556\/650.2024.33043"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Heged\u0171s F, S\u00fck\u00f6sd F, Tiszlavicz L, et al. Alectinib and mixed large\n cell neuroendocrine carcinoma of the lung. [Az alectinib \u00e9s a t\u00fcd\u0151 kevert\n nagysejtes neuroendokrin carcinom\u00e1ja.] Orv Hetil. 2023; 164: 548-554.\n [Hungarian] https:\/\/doi.org\/10.1556\/650.2023.32738","DOI":"10.1556\/650.2023.32738"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE, et al. Blindness caused by\n photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;\n 81: 606-613.\n https:\/\/doi.org\/10.1016\/0002-9394(76)90125-2","DOI":"10.1016\/0002-9394(76)90125-2"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv\n Ophthalmol. 2003; 48: 12-38.\n https:\/\/doi.org\/10.1016\/S0039-6257(02)00416-2","DOI":"10.1016\/S0039-6257(02)00416-2"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: a\n novel autoantibody reaction associated with small-cell lung carcinoma. J\n Neuroophthalmol. 1997; 17: 77-83.\n https:\/\/doi.org\/10.1097\/00041327-199706000-00001","DOI":"10.1097\/00041327-199706000-00001"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Mahdi N, Faia LJ, Goodwin J, et al. A case of autoimmune retinopathy\n associated with thyroid carcinoma. Ocul Immunol Inflamm. 2010; 18: 322-323.\n https:\/\/doi.org\/10.3109\/09273941003802379","DOI":"10.3109\/09273941003802379"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Ferreyra HA, Jayasundera T, Khan NW, et al. Management of autoimmune\n retinopathies with immunosuppression. Arch Ophthalmol. 2009; 127: 390-397.\n https:\/\/doi.org\/10.1001\/archophthalmol.2009.24","DOI":"10.1001\/archophthalmol.2009.24"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Espandar L, O\u2019Brien S, Thirkill C, et al. Successful treatment of\n cancer-associated retinopathy with alemtuzumab. J Neurooncol. 2007; 83: 295-302.\n https:\/\/doi.org\/10.1007\/s11060-006-9326-7","DOI":"10.1007\/s11060-006-9326-7"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Huynh N, Shildkrot Y, Lobo AM, et al. Intravitreal triamcinolone for\n cancer-associated retinopathy refractory to systemic therapy. J Ophthalmic\n Inflamm Infect. 2012; 2: 169-171.\n https:\/\/doi.org\/10.1007\/s12348-012-0067-9","DOI":"10.1007\/s12348-012-0067-9"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Jacobson DM, Adamus G. Retinal anti-bipolar cell antibodies in a\n patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol.\n 2001; 131: 806-808.\n https:\/\/doi.org\/10.1016\/S0002-9394(00)00925-9","DOI":"10.1016\/S0002-9394(00)00925-9"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Berson EL, Lessell S. Paraneoplastic night blindness with malignant\n melanoma. Am J Ophthalmol. 1988; 106: 307-311.\n https:\/\/doi.org\/10.1016\/S0002-9394(14)76622-X","DOI":"10.1016\/S0002-9394(14)76622-X"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic\n characteristics of melanoma-associated retinopathy syndrome: eleven new cases\n and a review of 51 previously published cases. J Neuroophthalmol. 2001; 21:\n 173-187.\n https:\/\/doi.org\/10.1097\/00041327-200109000-00004","DOI":"10.1097\/00041327-200109000-00004"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Kondo M, Sanuki R, Ueno S, et al. Identification of autoantibodies\n against TRPM1 in patients with paraneoplastic retinopathy associated with ON\n bipolar cell dysfunction. PLOS ONE 2011; 6: e19911.\n https:\/\/doi.org\/10.1371\/journal.pone.0019911","DOI":"10.1371\/journal.pone.0019911"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Dhingra A, Fina ME, Neinstein A, et al. Autoantibodies in\n melanoma-associated retinopathy target TRPM1 cation channels of retinal ON\n bipolar cells. J Neurosci. 2011; 31: 3962-3967.\n https:\/\/doi.org\/10.1523\/JNEUROSCI.6007-10.2011","DOI":"10.1523\/JNEUROSCI.6007-10.2011"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Cohen DC, Sumaroka A, Paulos JA, et al. Anti-TRPM1\n autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered\n by immunotherapy recapitulates functional and structural details of\n TRPM1-associated congenital stationary night blindness. Am J Ophthalmol Case\n Rep. 2024; 36: 102098.\n https:\/\/doi.org\/10.1016\/j.ajoc.2024.102098","DOI":"10.1016\/j.ajoc.2024.102098"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Audemard A, de Raucourt S, Miocque S, et al. Melanoma-associated\n retinopathy treated with ipilimumab therapy. Dermatology 2013; 227: 146-149.\n https:\/\/doi.org\/10.1159\/000353408","DOI":"10.1159\/000353408"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Handler MZ, Mruthyunjaya P, Nelson K. Melanoma-associated\n retinopathy: a presenting sign of metastatic disease. J Am Acad Dermatol. 2011;\n 65: e 9-e11.\n https:\/\/doi.org\/10.1016\/j.jaad.2010.09.015","DOI":"10.1016\/j.jaad.2010.09.015"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Powell SF, Dudek AZ. Treatment of melanoma-associated retinopathy.\n Curr Treat Options Neurol. 2010; 12: 54-63.\n https:\/\/doi.org\/10.1007\/s11940-009-0057-x","DOI":"10.1007\/s11940-009-0057-x"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Poujade L, Samaran Q, Mura F, et al. Melanoma-associated retinopathy\n during pembrolizumab treatment probably controlled by intravitreal injections of\n dexamethasone. Doc Ophthalmol. 2021; 142: 257-263.\n https:\/\/doi.org\/10.1007\/s10633-020-09795-8","DOI":"10.1007\/s10633-020-09795-8"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Tshuva-Bitton R, Ostrovsky M, Vishnevskia-Dai V, et al. A seven-year\n electroretinography follow-up of a patient with melanoma-associated retinopathy\n stabilized on pembrolizumab treatment. Am J Ophthalmol Case Rep. 2025; 38:\n 102307. https:\/\/doi.org\/10.1016\/j.ajoc.2025.102307","DOI":"10.1016\/j.ajoc.2025.102307"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Koreen L, He SX, Johnson MW, et al. Anti-retinal pigment epithelium\n antibodies in acute exudative polymorphous vitelliform maculopathy: a new\n hypothesis about disease pathogenesis. Arch Ophthalmol. 2011; 129: 23-29.\n Erratum: Arch Ophthalmol. 2011; 129: 287.\n https:\/\/doi.org\/10.1001\/archophthalmol.2010.316","DOI":"10.1001\/archophthalmol.2010.316"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Eksandh L, Adamus G, Mosgrove L, et al. Autoantibodies against\n bestrophin in a patient with vitelliform paraneoplastic retinopathy and a\n metastatic choroidal malignant melanoma. Arch Ophthalmol. 2008; 126: 432-435.\n https:\/\/doi.org\/10.1001\/archopht.126.3.432","DOI":"10.1001\/archopht.126.3.432"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Aronow ME, Adamus G, Abu-Asab M, et al. Paraneoplastic vitelliform\n retinopathy: clinicopathologic correlation and review of the literature. Surv\n Ophthalmol. 2012; 57: 558-564.\n https:\/\/doi.org\/10.1016\/j.survophthal.2012.02.004","DOI":"10.1016\/j.survophthal.2012.02.004"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv\n Ophthalmol. 2003; 48: 12-38.\n https:\/\/doi.org\/10.1016\/S0039-6257(02)00416-2","DOI":"10.1016\/S0039-6257(02)00416-2"},{"key":"R30","unstructured":"Malik S, Furlan AJ, Sweeney PJ, et al. Optic neuropathy: a rare\n paraneoplastic syndrome. J Clin Neuroophthalmol. 1992; 12:\n 137-141."},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Sheorajpanday R, Slabbynck H, Van De Sompel W, et al. Small cell\n lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5\n paraneoplastic optic neuropathy. J Neuroophthalmol. 2006; 26: 168-172.\n https:\/\/doi.org\/10.1097\/01.wno.0000235578.80051.0e","DOI":"10.1097\/01.wno.0000235578.80051.0e"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody:\n marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001; 49:\n 146-154.\n https:\/\/doi.org\/10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO2-E;","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune\n optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol. 2003; 54:\n 38-50. https:\/\/doi.org\/10.1002\/ana.10587","DOI":"10.1002\/ana.10587"},{"key":"R34","unstructured":"Machemer R. On the pathogenesis of the flat malignant melanoma. [Zur\n Pathogenese des fl\u00e4chenhaften malignen Melanoms.] Klin Monbl Augenheilkd. 1966;\n 148: 641-652. [German]"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Barr CC, Zimmerman LE, Curtin VT, et al. Bilateral diffuse\n melanocytic uveal tumors associated with systemic malignant neoplasms: a\n recently recognized syndrome. Arch Ophthalmol. 1982; 100: 249-255.\n https:\/\/doi.org\/10.1001\/archopht.1982.01030030251003","DOI":"10.1001\/archopht.1982.01030030251003"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Miles SL, Niles RM, Pittock S, et al. A factor found in the IgG\n fraction of serum of patients with paraneoplastic bilateral diffuse uveal\n melanocytic proliferation causes proliferation of cultured human melanocytes.\n Retina 2012; 32: 1959-1966.\n https:\/\/doi.org\/10.1097\/IAE.0b013e3182618bab","DOI":"10.1097\/IAE.0b013e3182618bab"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Mittal R, Cherepanoff S, Thornton S, et al. Bilateral diffuse uveal\n melanocytic proliferation: molecular genetic analysis of a case and review of\n the literature. Ocul Oncol Pathol. 2015; 2: 94-99.\n https:\/\/doi.org\/10.1159\/000440766","DOI":"10.1159\/000440766"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Gass JD, Gieser RG, Wilkinson CP, et al. Bilateral diffuse uveal\n melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol.\n 1990; 108: 527-533.\n https:\/\/doi.org\/10.1001\/archopht.1990.01070060075053","DOI":"10.1001\/archopht.1990.01070060075053"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Schelvergem KV, Wirix M, Nijs I, et al. Bilateral diffuse uveal\n melanocytic proliferation with good clinical response to plasmapheresis and\n treatment of the primary tumor. Retin Cases Brief Rep. 2015; 9: 106-108.\n https:\/\/doi.org\/10.1097\/ICB.0000000000000104","DOI":"10.1097\/ICB.0000000000000104"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/48\/article-p1898.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/48\/article-p1898.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/48\/article-p1898.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:57:12Z","timestamp":1785491832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/48\/article-p1898.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":39,"journal-issue":{"issue":"48"},"URL":"https:\/\/doi.org\/10.1556\/650.2025.33434","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,30]]}}}